Difference between revisions of "Team:Aix-Marseille/HP/Silver"

Line 3: Line 3:
 
[[File:Tree.png|500px|right|thumb|Human Practices Development]]
 
[[File:Tree.png|500px|right|thumb|Human Practices Development]]
  
−
We have thought about the Human Practices from the very beginning of [[Team:Aix-Marseille/Project|'''KILL XYL''']]. At the beginning of the project, we drew the limits of the project and discussed the different actors that were going to be involved and affected by our scientific approach.  
+
Thinking about Human Practice, it's to be able to see beyond the lab and see the society's implication of any project. Our team was especially concerned about the Human Practices during all the time of the competition. We question ourselves about a large number of topics :
−
This way our project could be as adapted as much as possible to the needs of society.
+
  
−
Then, the more our [[Team:Aix-Marseille/Project|project]] advanced and defined itself, the more we worked on the practical side of Human Practices.
+
* How do we [[Team:Aix-Marseille/HP/Surveys#Internal_surveys|present ourself]] in front of funders?
 +
* How aware is the public of [[Team:Aix-Marseille/Xylella_fastidiosa|''Xylella fastidiosa'']]?
 +
* What is the [[Team:Aix-Marseille/HP/Surveys|public opinion]] about the GMO subject?
 +
* Was the form of our cure practical for the [[Team:Aix-Marseille/HP/Surveys|farmers]]?
 +
* Does the farmers feel support in their fight?
 +
* Is our process and project [[Team:Aix-Marseille/Safety|safe]] for both consumers and environment?
 +
* Are we relevant in our fighting process, from an [[Team:Aix-Marseille/HP/Interviews|expert opinion]]?
 +
* Does the [[Team:Aix-Marseille/Engagement#Marseille_Science_Village|child]] understand the stake of the scientific research?
 +
* Where did our project stand in regards to the [[Team:Aix-Marseille/Legislation|GMO law]]?
  
−
First and foremost [[Team:Aix-Marseille/Safety|safety]]  is crucial in a lab. To work in synthetic biology, we ask ourselves about the consequences of our manipulation and the safety level of each organism that we used. We also always made sure to work in the best conditions. We didn't experiment with P2 level organisms. We also wanted to make sure that our product, especially our phage-like particle, as it is a GMO, is environmentally friendly and doesn't pollute the soil or harm plants.  
+
By this questioning, we make sure that our project fills society criteria. It made us prudent, engaged, ethical and open minded.  
−
To do so, we [[Team:Aix-Marseille/M13_test|tested]] our phages in various conditions.
+
We also improve ourselves after every answer we get.
−
 
+
−
To know about the olive growers and farmer’s opinions, we contacted them and did [[Team:Aix-Marseille/HP/Surveys|a survey]],
+
−
first via the web and then in person, during [[Team:Aix-Marseille/Engagement#Salon_des_Agricultures_de_Provence|an agricultural fair]].  
+
−
This approach helped us to figure out their needs and their thoughts about [[Team:Aix-Marseille/Xylella_fastidiosa|''Xylella fastidiosa'']], so we could work accordingly.
+
−
 
+
−
We got [[Team:Aix-Marseille/HP/Interviews|advice]] from several different experts :  [[Team:Aix-Marseille/HP/Interviews#Mireille_ANSALDI|Mireille Ansaldi]], the PI of the phage cycle and bacteria metabolism group in the LCB; [[Team:Aix-Marseille/HP/Interviews#Marie-Agn.C3.A8s_JACQUES|Marie-Agnès Jacques]], a researcher and expert on [[Team:Aix-Marseille/Xylella_fastidiosa|''X. fastidiosa'']], and [[Team:Aix-Marseille/HP/Interviews#Jacques_VAN_HELDEN|Jacques Van Helden]], a professor of bioinformatics at Aix-Marseille University who specializes in the analysis of regulatory sequences.
+
−
 
+
−
Ms Jacques, the [[Team:Aix-Marseille/Xylella_fastidiosa|''X. fastidiosa'']] specialist and agronomist, when we consulted her about the relevance of our project, warned us we would be affected by the legislation on GMO's and the authorization of plant treatment products.
+
−
We therefore began a complete study of relevant [[Team:Aix-Marseille/Legislation|french and European law]], thanks to a collaboration with the [https://2017.igem.org/Team:Evry_Paris-Saclay|Evry Paris-Saclay] team.
+
−
This allowed us to see the different steps necessary to sell our product in France and in Europe.
+
−
 
+
−
To sum up, our project grew entwined with the human practices from the very beginning.
+
  
 
<div class="row-icons white-icons">
 
<div class="row-icons white-icons">

Revision as of 17:36, 1 November 2017

Human Practices

Human Practices Development

Thinking about Human Practice, it's to be able to see beyond the lab and see the society's implication of any project. Our team was especially concerned about the Human Practices during all the time of the competition. We question ourselves about a large number of topics :

  • How do we present ourself in front of funders?
  • How aware is the public of Xylella fastidiosa?
  • What is the public opinion about the GMO subject?
  • Was the form of our cure practical for the farmers?
  • Does the farmers feel support in their fight?
  • Is our process and project safe for both consumers and environment?
  • Are we relevant in our fighting process, from an expert opinion?
  • Does the child understand the stake of the scientific research?
  • Where did our project stand in regards to the GMO law?

By this questioning, we make sure that our project fills society criteria. It made us prudent, engaged, ethical and open minded. We also improve ourselves after every answer we get.

  • T--Aix-Marseille--survey.pngSurvey
  • InterviewInterviews
  • LegislationLegislation
  • T--Aix-Marseille--Public.pngPublic Engagement